NCT04930900View on ClinicalTrials.gov

Pharmacokinetics of Adrenaline After Administration of ARS -1 in Subjects With Upper Respiratory Tract Infection

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 9, 2021

Primary Completion Date

March 31, 2022

Study Completion Date

July 25, 2022

Conditions
Upper Respiratory Tract Infection
Interventions
DRUG

ARS-1 with URTI

ARS-1

DRUG

ARS-1 without URTI

ARS-1 without URTI

Trial Locations (1)

2100

Anthony McGirr, Brookvale

Sponsors
All Listed Sponsors
lead

ARS Pharmaceuticals, Inc.

INDUSTRY